Literature DB >> 1586597

Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.

G Forster1, T G Cooke, L D Cooke, P D Stanton, G Bowie, P M Stell.   

Abstract

The cell kinetics of 82 squamous cell carcinomas of the head and neck were studied by in vivo administration of the thymidine analogue, bromodeoxyuridine (BrdUrd). Ploidy, BrdUrd labelling index (LI), duration of S-phase (Ts), potential doubling time (Tpot) and S-phase fraction (SPF) were measured by flow cytometry on 50 microns paraffin embedded sections. The range of values obtained compared well with other in vivo cell kinetic studies of head and neck cancer. Aneuploid tumours had a significantly higher BrdUrd labelling index and SPF, and a short Tpot than diploid tumours. To validate the use of 50 microns sections for measuring cell kinetic parameters by flow cytometry a comparison of values obtained by 50 microns sections and small blocks of tissue was made. No significant difference was found between the two methods. Reproducibility of values between two consecutive thick sections was also good. We conclude that reproducible cell kinetic measurements can be made in tumour samples using 50 microns sections of BrdUrd labelled tissue.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1586597      PMCID: PMC1977390          DOI: 10.1038/bjc.1992.147

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  34 in total

1.  A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.

Authors:  A C Begg; N J McNally; D C Shrieve; H Kärcher
Journal:  Cytometry       Date:  1985-11

2.  The influence of tumour cell DNA abnormalities on survival in colorectal cancer.

Authors:  N C Armitage; R A Robins; D F Evans; D R Turner; R W Baldwin; J D Hardcastle
Journal:  Br J Surg       Date:  1985-10       Impact factor: 6.939

3.  Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine.

Authors:  F Dolbeare; H Gratzner; M G Pallavicini; J W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

4.  Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.

Authors:  D W Hedley; M L Friedlander; I W Taylor
Journal:  Cytometry       Date:  1985-07

5.  What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation?

Authors:  K R Trott; J Kummermehr
Journal:  Radiother Oncol       Date:  1985-01       Impact factor: 6.280

6.  Variations in the [3H]thymidine labeling of S-phase cells in solid mouse tumors.

Authors:  D C Allison; P F Ridolpho; S Anderson; K Bose
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

7.  The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.

Authors:  G D Wilson; N J McNally; E Dunphy; H Kärcher; R Pfragner
Journal:  Cytometry       Date:  1985-11

8.  DNA ploidy and survival in breast cancer patients.

Authors:  C J Cornelisse; C J van de Velde; R J Caspers; A J Moolenaar; J Hermans
Journal:  Cytometry       Date:  1987-03

9.  Ploidy as a prognostic indicator in end stage squamous cell carcinoma of the head and neck region treated with cisplatinum.

Authors:  L D Cooke; T G Cooke; F Bootz; G Forster; T R Helliwell; D Spiller; P M Stell
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

10.  DNA measurement--an objective predictor of response to irradiation? A review of 24 squamous cell carcinomas of the oral cavity.

Authors:  G Franzén; C Klintenberg; J Olofsson; B Risberg
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

View more
  9 in total

Review 1.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

2.  Growth rate of lung metastases and S-phase fraction as determined by flow cytometry from the primary tumour in 25 patients with bone or soft-tissue sarcomas.

Authors:  C Blomqvist; R Huuhtanen; Y Pan; T Wiklund; M Tarkkanen; M Virolainen; B Tribukait
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

3.  The effect of targeted therapy on recruited cancer stem cells in a head and neck carcinoma model.

Authors:  Loredana G Marcu; David Marcu
Journal:  Cell Prolif       Date:  2017-08-30       Impact factor: 6.831

4.  Cyclin D1 expression does not effect cell proliferation in adenoid cystic carcinoma of the salivary gland.

Authors:  Ryuji Yasumatsu; Yuichiro Kuratomi; Torahiko Nakashima; Muneyuki Masuda; Tomoya Yamamoto
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-01-09       Impact factor: 2.503

5.  Growth patterns and cell kinetics of human osteosarcoma xenografts in serial passages in nude mice analyzed by in vivo labelling with iododeoxyuridine.

Authors:  L A Broström; S Crnalic; R Löfvenberg; L Boquist; R Stenling
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

6.  In silico study of the impact of cancer stem cell dynamics and radiobiological hypoxia on tumour response to hyperfractionated radiotherapy.

Authors:  L G Marcu; D Marcu; S M Filip
Journal:  Cell Prolif       Date:  2016-04-15       Impact factor: 6.831

7.  Cytokinetic analysis of lung cancer by in vivo bromodeoxyuridine labelling.

Authors:  M M Tinnemans; B Schutte; M H Lenders; G P Ten Velde; F C Ramaekers; G H Blijham
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

8.  Prospective evaluation of cell kinetics in head and neck squamous carcinoma: the relationship to tumour factors and survival.

Authors:  L D Cooke; T G Cooke; G Forster; A S Jones; P M Stell
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

9.  In silico modelling of a cancer stem cell-targeting agent and its effects on tumour control during radiotherapy.

Authors:  Loredana G Marcu; David Marcu
Journal:  Sci Rep       Date:  2016-08-30       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.